Citation 100156

OKI,T: MATSUZAWA,Y: YOSHIMOTO,A: NUMATA,K: KITAMURA,I: HORI,S: TAKAMATSU,A: UMEZAWA,H: ISHIZUKA,M: NAGANAWA,H: SUDA,H: HAMADA,M: TAKEUCHI,T:. (1975). NEW ANTITUMOR ANTIBIOTICS, ACLACINOMYCINS A AND B.. 28()

Citation Details

Title	NEW ANTITUMOR ANTIBIOTICS, ACLACINOMYCINS A AND B.
Authors	OKI,T: MATSUZAWA,Y: YOSHIMOTO,A: NUMATA,K: KITAMURA,I: HORI,S: TAKAMATSU,A: UMEZAWA,H: ISHIZUKA,M: NAGANAWA,H: SUDA,H: HAMADA,M: TAKEUCHI,T:
Year	1975
Volume	28
Issue

Summary

Year: 1975

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ACLACINOMYCIN A	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ACLACINOMYCIN A	ACTIVE
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	ACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ACLACINOMYCIN B	ACTIVE
5	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN B	ACTIVE
6	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ACLACINOMYCIN A	ACTIVE
7	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ACLACINOMYCIN B	ACTIVE
8	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ACLACINOMYCIN A	.
9	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ACLACINOMYCIN A	.
10	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ACLACINOMYCIN B	.
11	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ACLACINOMYCIN B	.
12	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	ACTIVE
13	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	ACTIVE
14	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	ACTIVE
15	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	ACTIVE
16	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	ACTIVE
17	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	ACTIVE
18	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	ACTIVE
19	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	ACTIVE
20	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	ACTIVE
21	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	ACTIVE
22	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	ACTIVE
23	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	INACTIVE
24	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	INACTIVE
25	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	INACTIVE
26	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	INACTIVE
27	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	ACTIVE
28	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ACLACINOMYCIN A	ACTIVE
29	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	PYRROMYCIN,1-DEOXY:	ACTIVE

Streptomyces galilaeus (STREPTOMYCETACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	CHEMICAL CONVERSION OFISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ACLACINOMYCIN AACLACINOMYCIN B	None